Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STC-15 with Toripalimab in Advanced Cancers and as Monotherapy in Sarcomas
NCT06975293Phase 2Recruiting
- Sponsor
- STORM Therapeutics
- Start
- May 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STC-15 in solid tumor, sarcoma, leiomyosarcoma (LMS), dedifferentiated liposarcoma (DDL), sponsored by STORM Therapeutics. Started May 2025; status: recruiting.
02
Drugs
STC-15
03
Conditions
solid tumorsarcomaleiomyosarcoma (LMS)dedifferentiated liposarcoma (DDL)
Beyond the preview
Go deeper on NCT06975293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06975293.